Your Article Summary
See Latest ArticlesOncolytic Viral Therapy of Malignant Glioma
Neurotherapeutics, 07/02/09
Parker JN et al. - Novel approaches to treatment of malignant glioma, the most frequently occurring primary brain tumor, have included the use of a wide range of oncolytic viral vectors. These vectors, either naturally tumor-selective, or engineered as such, have shown promise in the handful of phase I and phase II clinical trials conducted in recent years.
Related Articles
Enhanced specific delivery and targeting of oncolytic Sindbis viral vectors by modulating vascular leakiness in tumor
Cancer Gene Therapy, 10/07/09
Relevance Score: 80%
Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses
Oral Oncology, 10/23/09
Relevance Score: 68%
Reactivation of hepatitis B viral infection in inactive HBSAg carriers following anti-tumor necrosis factor-alpha therapy
Journal of Rheumatology, 10/05/09
Relevance Score: 68%
Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09
Relevance Score: 66%
Oncolytic virus therapy for prostate cancer
International Journal of Urology, 10/15/09
Relevance Score: 66%
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Foam sclerotherapy: cardiac and cerebral monitoring
Phlebology, 12/04/09
Narcolepsy: Clinical Decision Making for the Primary Care Physician
Southern Medical Journal, 12/04/09
Lipid profile in normal weight migraineurs – evidence for cardiovascular risk
European Journal of Neurology, 12/04/09